[SaNOtize in The Telegraph] Covid nasal spray that halves the time you test positive on a PCR test could be available in UK soon
Read more here.
Read MoreFeb 11, 2022 | News Center, Newsticker
A treatment for COVID-19 that was developed in British Columbia has been approved for sale in India, where it could be shipped to pharmacies as early as Friday – though the product has so far received limited support in Canada. Read more...
Read MoreFeb 9, 2022 | News Center
VANCOUVER, British Columbia & MUMBAI, India–(BUSINESS WIRE)–Canadian pharmaceutical company SaNOtize Research & Development Corp., (SaNOtize), and Glenmark Pharmaceuticals Limited (Glenmark), a global, innovation-driven pharmaceutical company, today announced successful results of Phase 3 clinical trials and approval from India’s drug regulator for the treatment of adult patients with COVID-19 who have a risk of progression of the disease. Read more...
Read MoreFeb 9, 2022 | News Center
SaNOtize, an OurCrowd portfolio company, has shown to be 99% effective against COVID-19 in a phase three trial, according to a note distributed by OurCrowd. Simultaneously, the treatment has received regulatory approval in India. OurCrowd has participated in the funding of the firm providing access to individual investors. Read more...
Read MoreDec 23, 2021 | News Center, Newsticker
As the world remains anxious for innovative tools to tackle the coronavirus, drugmaker Glenmark Pharmaceuticals expects the antiviral nasal spray from SaNOtize to be available in India in three months. Read more...
Read More